The AUC, sensitivity, and specificity of IL34-FS were, respectively, 0.86, 75.2%, and 85.0% for significant fibrosis (≥Stage 2); 0.88, 81.7%, and 79.4% for advanced fibrosis (≥Stage 3); 0.91, 83.3%, and 85.6% for liver cirrhosis (Stage 4) (Table 4). This evidence concerns the gene IL34 and cirrhosis of liver.